Adaptimmune Therapeutics PLC - SPONDS ADR (ADAP)

Q1 2021 13F Portfolio Holders as of 3/31/2021

Type / Class
Equity / SPONDS ADR
Number of holders
80
Total Shares
117M
Shares change
-664K
Total reported value, excl. options
$624M
Value change
-$3.87M
Put/Call ratio
1.06
Number of buys
42
Number of sells
-38
Price
$5.31
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.